Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Mary Labus
Clinical Research Assistant
Department of Emergency Medicine
Overview
Research
More
Collaboration
(15)
Heidi Erickson
Mutual work: 1 Grant
Collaboration Details
Farshad Shirazi
Mutual work: 1 Grant
Collaboration Details
Jarrod Mosier
Mutual work: 6 Grants
Collaboration Details
Karen Lutrick
Mutual work: 3 Grants
Collaboration Details
Christian Bime
Mutual work: 2 Grants
Collaboration Details
Page 1 of 3
Previous page
Next page
Grants
(6)
Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Varespladib Followed by Oral Varespladib in Addition to Standard of Care in Subje
Active
·
2023
·
$0 / $1.5M
·
External
undefined (CD)
pharmaceuticals,
clinical trials,
drug efficacy,
safety assessment,
standard of care
A Phase III, Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infec
Active
·
2023
·
$0 / $1.3M
·
External
undefined (CD)
clinical trials,
immunotherapy,
infectious diseases,
respiratory medicine,
drug safety
A Phase 2a, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Alt-100 in Patients With Moderate to Severe Acute Respiratory Distress Syndrome (ARDS)
Active
·
2023
·
$0 / $498.4K
·
External
undefined (CD)
clinical trial,
respiratory distress,
drug efficacy,
safety assessment
Novel ?2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial
Active
·
2023
·
$0 / $45.8K
·
External
undefined (CD)
thrombolysis,
antiplasmin,
intravascular,
clinical trial,
lysis
A Multicenter, Adaptive, Randomized, Controlled Trial Platform To Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized Patients with Respiratory Infections / Appendix E-1: Shio
Active
·
2022
·
$0 / $1.5M
·
External
undefined (CD)
respiratory infections,
hospitalized patients,
treatment strategies,
randomized controlled trial,
efficacy evaluation
Page 1 of 2
Previous page
Next page